Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Market Street HealthCare Partners is a private equity sponsor focused on investing in healthcare companies rather than developing therapeutics itself. Available directory sources describe the firm as U.S.-based, founded in 2022, and headquartered in The Woodlands, Texas, with investment interest across diagnostics, freestanding medical centers, medical devices, and biotech. The organization appears to be a small, private investment platform led by healthcare and banking executives. It is best characterized as a healthcare-focused financial sponsor, not an operating biotech, pharma, or care delivery company. Because public information is limited, there is no evidence of an internal drug pipeline, clinical-stage programs, or proprietary therapeutic platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Market Street HealthCare Partners.